Abeona Therapeutics, Inc.
(NASDAQ : ABEO)

( )
ABEO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
-2.08%184.302.8%$293.03m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
-0.60%23.272.1%$266.77m
ZTSZoetis, Inc. Class A
0.00%89.281.9%$151.16m
MYLMylan N.V.
-0.72%37.213.2%$95.73m
TXMDTherapeuticsMD, Inc.
-2.23%6.1427.8%$13.06m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
-1.05%35.692.0%$8.74m
ABEOAbeona Therapeutics, Inc.
-2.44%14.007.9%$5.94m
KINKindred Biosciences, Inc.
-1.84%13.350.3%$2.28m
LFVNLifeVantage Corporation
-3.26%12.483.3%$2.25m
JAGXJaguar Animal Health, Inc.
1.46%0.550.7%$0.06m
CPHIChina Pharma Holdings, Inc.
-5.54%0.210.1%$0.03m

Company Profile

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Dallas, TX.